Northwire Canada EditionSaturday, July 25, 2026
Northwire
B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9% B 0.150 +0.0% IFOS 2.28 −2.6% IMM 0.060 +0.0% ROCK 3.38 −1.7% NVX 0.250 −7.4% HAR 0.050 +0.0% YGT 0.175 +0.0% GEN 0.070 −nan% CRB 0.040 +14.3% MSA 7.07 +2.2% AEM 204.81 +0.7% OPW 0.105 +5.0% GRL 0.275 −1.8% AIS 0.150 +0.0% CUU 0.580 −1.7% SOMA 0.720 +5.9%
Financings

Graphene Manufacturing increases offering to $6-million

GMG · Price

Executive Summary

  • Graphene Manufacturing Group Ltd. has upsized its previously announced bought deal public offering from approximately $5 million to approximately $6 million in gross proceeds due to strong investor demand.
  • The offering consists of 6,666,667 units priced at C$0.90 per unit, with Red Cloud Securities Inc. acting as the sole underwriter and bookrunner.
  • Net proceeds will be used to finance continuing operations, including commercial development, product development, and working capital.

Key Details

  • Gross Proceeds: Approximately C$6 million (upsized from C$5 million).
  • Units Sold: 6,666,667 units.
  • Price Per Unit: C$0.90.
  • Underwriter: Red Cloud Securities Inc. (Sole underwriter and bookrunner).
  • Unit Composition: Each unit consists of one common share and one common share purchase warrant.
  • Warrant Terms: Each warrant entitles the holder to purchase one common share at an exercise price of $1.35. Warrants are exercisable for 36 months after the closing date.
  • Overallotment Option: The underwriter has an option to purchase up to 15% additional units (approx. 1,000,000 units) at the offering price to cover overallotments and for market stabilization, exercisable within 30 days of closing.
  • Use of Proceeds: Financing continuing operations, including commercial development, product development, and working capital.
  • Closing Date: Expected on or about September 3, 2025, subject to regulatory approvals (including TSX Venture Exchange listing approval).
  • Regulatory Filings: A prospectus supplement will be filed with securities regulatory authorities in Canadian provinces/territories (except Quebec) and the offering will be sold in the US on a private placement basis.

Notable Quotes

  • No direct quotes from the CEO or President were included in the provided text.
Read the original news release →

More from Graphene Manufacturing Group Ltd